Michael B. Atkins, MD: New Therapies and New Questions for Metastatic Melanoma
Dr. Michael Atkins discusses how the approval of several new drugs to treat patients with malignant melanoma is creating tremendous excitement, but also lots of new questions.
This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012.
Michael B. Atkins, MD is the Deputy Director of the Georgetown Lombardi Comprehensive Cancer Center.
The Group Room at the American Society of Clinical Oncology (ASCO) Annual Meeting 2012 was made possible, in part, by: